Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-09-20

Clinical Trial Update: Pharmacological Effects of Pascoflair® on Brain Activity in Patients Suffering From Test Anxiety [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the pharmacological effects of Pascoflair on brain activity in individuals with test anxiety and stress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PASCOFLAIR (Passiflora incarnata extract)
  • Passiflora incarnata (Passiflora incarnata)

Snippet

Sponsor: Pascoe Pharmazeutische Praeparate GmbH | Conditions: Stress, Brain Activity | Phase 4 | Status: COMPLETED